Substance P and Affective Disorders: New Treatment Opportunities by Neurokinin 1 Receptor Antagonists?

Publisher： Karger

E-ISSN： 1423-0224|45|1|2-6

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.45, Iss.1, 2002-03, pp. : 2-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Severe Tardive Dyskinesia in Affective Disorders: Treatment with Vitamin E and C

By  

Neuropsychobiology, Vol. 46, Iss. 1, 2003-02 ,pp. : 28-30

Karger

Access to resources Recommend Favorite

Soluble Intracellular Adhesion Molecule-1 in Patients with Unipolar or Bipolar Affective Disorders: Results from a Pilot Trial

By  

Neuropsychobiology, Vol. 74, Iss. 1, 2016-07 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Association Study of Suicidal Behavior and Affective Disorders with a Genetic Polymorphism in ABCG1, a Positional Candidate on Chromosome 21q22.3

By  

Neuropsychobiology, Vol. 42, Iss. 1, 2000-11 ,pp. : 22-25

Karger

Access to resources Recommend Favorite

Lithium-Induced EEG Changes in Patients with Affective Disorders

By  

Neuropsychobiology, Vol. 42, Iss. 1, 2000-11 ,pp. : 33-37

Karger

Access to resources Recommend Favorite

Effects of NMDA Receptor Antagonists on D1 Dopamine Receptor-Mediated Changes in Striatal Immediate Early Gene Expression: Evidence for Involvement of Pharmacologically Distinct NMDA Receptors?

By  

Developmental Neuroscience, Vol. 20, Iss. 2-3, 1998-07 ,pp. : 216-228

Karger

Access to resources Recommend Favorite